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ABSTRACT
Cholesteatoma is a destructive pathology characterized with progressive 
and chronic infiltration of keratinized squamous epithelium that can be 
seen the middle ear and mastoid regions of temporal bone. It has serious 
intra and extracranial complications which can be difficult to manage. 
Embryologic remnants of squamous epithelium, squamous metaplasia of 
middle ear epithelium, migration of epidermal cells from external ear canal 
and tympanic membrane and cell seeding because of middle ear surgery or 
trauma were all stated as causes of cholesteatoma. Cytokeratins are impor-
tant markers of cell differentiation. The patterns of cytokeratin expression 
correlate well with the state of keratinocyte proliferation, migration and 
differentiation. These patterns are known to be affected during the forma-
tion of cholesteatoma. Increasing our knowledge about cytokeratin pat-
terns may help us understand the unknown formation of cholesteatoma. In 
this review article, a literature survey was done about cytokeratin patterns 
of cholesteatoma.
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KOLESTEATOMADA SİTOKERATİN PATERNİNE GENEL BİR BAKIŞ
Kolesteatoma, temporal kemiğin özellikle orta kulak ve mastoid bölgele-
rinde görülen, keratinize yassı epitelin ilerleyici ve kronik infiltrasyonu ile 
karakterize tahrip edici bir patolojidir. Tedavisi güç olabilen ciddi kafa içi ve 
kafa dışı komplikasyonları vardır. Kolesteatoma oluşumunda; yassı epitelin 
embryolojik kalıntıları, orta kulak epitelinin yassı epitel metaplazisi, dış 
kulak yolu ve kulak zarından epidermal hücrelerin göç etmesi ve orta kulak 
cerrahisi yada travma nedeniyle hücre ekimi gibi nedenler suçlanmaktadır. 
Sitokeratinler, hücre farklılaşmasında önemli belirleyicilerdir. Sitokeratin 
oluşum paternleri; keratinosit proliferasyonu, göç ve farklılaşma ile yüksek 
oranda ilişkilidir. Bu paternlerin, kolesteatoma oluşumu sırasında etkili ol-
duğu bilinmektedir. Sitokeratin paternleri hakkında bilgilerimiz arttıkça, 
kolesteatoma oluşumu hakkındaki bilgilerimiz de artacaktır. Bu makalede, 
kolesteatomada sitokeratin paternleri hakkında bir literatür taraması yapıl-
mıştır.
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Cholesteatoma is a pathologic process with progressive and continuous invasion of keratinizing squamous epithelium in middle ear and mastoid part of tempo-
ral bone. Cholesteatoma was defined as a tumoral process 
by a French pathologist, Cruveilhier (1829). Cruveilhier was 
the first pointed out the pathological characteristics of chole-
steatoma. Johannes Mueller, a German physiologist, defined 
the process as “cholesteatoma” because of the cholesterol 
in the center of the tumour which was a wrong meaning 
(1830). Mueller described cholesteatoma as a fat tumor com-
posed of layers, and different from other fatty tumors with 
presence of bile salts and fatty acids (cholesterin) dispersed 
between cells. Gray suggested the term “skin in the wrong 
place” (1). Today, we know that cholesteatoma is a tumour of 
keratin and cholesterin crystals. Because of this, the term of 
keratoma seems even better.
Treatment of this inflammatory condition which has se-
rious intracranial and extracranial complications makes 
difficulties for ear surgeons since many years (2-4). 
Marsupialization of the middle ear was the best treat-
ment modality before antibiotic era. In this period, all op-
erations were radical mastoid surgeries and the only goal 
was to save life.
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In later years, some surgeons have tried to more conserva-
tive methods because of the morbidity of radical proce-
dures (modified radical operation – Bryant 1906, radical 
conservative operation – Bondy 1910). After World War II, 
infections were taken to control with the introduction of 
antibiotics. With developing technological possibilities, 
tympanoplastic operations began to take place in surgical 
interventions. At these years again, self-containing mech-
anism of the outer ear canal and the mucous layer of mid-
dle ear were defined (5). In the next period, closed tech-
niques (Jansen – posterior tympanotomy (6), Sheey et al 
– intact canal wall (7), Portmann – closed technique (8)) 
were popularized. Today, advantages and disadvantages 
of open and versus closed techniques are being discussed 
with notifying many surgical serials (9,10).
In the formation of cholesteatoma; embryological rem-
nants of squamous epithelium (11), squamous metaplasia 
of middle ear epithelium (12), migration of epithelial cells 
from external auditory meatus or tympanic membrane 
through retraction, or through basal cell proliferation or 
through perforated tympanic membrane (13), sprinkled 
of epithelial cells by middle ear surgery or trauma (14) 
were all blamed.
Cholesteatoma can be studied under four headings:
1) external ear canal cholesteatoma,
2) iatrogenic cholesteatoma,
3) congenital cholesteatoma,
4) acquired cholesteatoma. 
Acquired cholesteatoma is divided into two parts: prima-
ry acquired and secondary acquired. In primary acquired 
cholesteatoma, the Eustachian tube is open and the tym-
panic membrane is intact. Its formation is considered 
from expansion of external tympanic membrane epithe-
lium to middle ear cavity, not remnants of embryological 
life. In secondary acquired cholesteatoma, cholesteatoma 
is formed by migration of epithelium to middle ear by 
way of marginal or attic perforation. Invagination, basal 
cell hyperplasia, otitis media with effusion and metaplasia 
are accused in primary acquired cholesteatoma, whereas 
implantation and epithelial invasion are accused in sec-
ondary acquired cholesteatoma and iatrogenic chole-
steatoma. Congenital cholesteatoma can take origin from 
petrous apex, mastoid region, middle ear and external 
auditory canal (15).
The most appropriate description for cholesteatoma is, 
“skin in the wrong place with wrong healing process“. 
Cholesteatoma consist of keratinizing squamous epithe-
lium with a sharp boundary across to middle ear muco-
sa. It has all the layers of skin with different thicknesses. 
Continuous renewal layer of the skin is the basal germina-
tive layer. It produces new cells consistently. Skin cells are 
constantly renewed while dead cells are thrown out by 
desquamated lamella. Dead cells form the white lamella 
of cholesteatoma by accumulation. Basal germinative lay-
er with surrounding connective tissue called corion, gets 
the name of “matrix” and creates the generative layer of 
cholesteatoma. Matrix is the part of cholesteatoma which 
in contact with middle ear walls. Continuous keratin pro-
duction is the important characteristic of cholesteatoma. 
As a result; cholesteatoma is a pseudo-tumor with accu-
mulation of desquamated epithelium and keratin comes 
from basal germinative epithelium and stratum (st) cor-
neum (16,17).
Dead cells in the matrix are settled in layers on each other. 
This arrangement is lost away from matrix, because of this, 
the center of cholesteatoma has a amorphous character. 
As the infection progresses, heavy fat acids and cholester-
in crystals which give the bad smell of cholesteatoma 
arise. In addition to this, granulation tissue and a papillary 
structure are observed around the matrix (16,17).
The epithelium of cholesteatoma is thinner than skin. It 
consists of four layers: st. germinativum, st.spinosum, st. 
granulosum and st. corneum. Keratin arises from the cells 
of st. corneum.
Why does the skin of external canal moving into mid-
dle ear and how do the epidermal cell hyperplasia and 
keratinization take place?. Answers of these questions are 
investigated with immunohistochemical studies. Skin of 
the external ear canal and cholesteatoma originate from 
the same cells. The differences are the presence of papil-
lary proliferation reach out to the subepithelial layer and 
Langerhans cells. Their ratio is higher in cholesteatoma 
than canal skin. They are scattered at different levels in 
stratified squamous epithelium and infiltrated to the 
underlying subepithelial tissue. Langerhans cells which 
involved in st. spinosum are placed between keratino-
cytes. Smaller Merkel cells are present in st. germinativum. 
Bremond pointed out that these cells are not present in 
normal middle ear mucosa, he also added determining of 
these cells in the middle ear is the proof of the migration 
theory (16).
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Kaneko et al (18) demonstrated keratin directly penetrat-
ed into destructed bone tissue because of fragmentation 
of matrix. According to Abramson et al (19), frequent oc-
currence of bone resorption is related to excessive pro-
duction of keratin and epithelial debris. Creating foreign 
body reaction by keratin and epithelial debris was dem-
onstrated in animal studies by Kaneko et al and Abramson 
et al. Keratin also makes an ideal environment for microor-
ganisms. It provides high concentrations of microorgan-
isms by blocking of drainage of inflammatory flow and 
also makes a low oxygenated ambient for evolving of an-
aerobic bacteria.
The basic proteins of the cytoskeleton are; microtubules, 
microfilaments and intermediate filaments. Intermediate 
filaments are divided into five groups according to specif-
ic appearances: vimentin, desmin, glial fibrin protein, neu-
rofilaman proteins and cyrokeratins (20). Cytokeratins (Ck) 
are the most complex and diverse polypeptide groups 
between the intermediate filaments of human epithelial 
cells and are important determinants of all differentiation 
(21-23). Cytokeratins have been introduced as markers of 
cellular proliferation. They are insoluble, low-molecular –
weight proteins. Special forms are found according to the 
type of epithelium (e.g. simple, stratified, transitional), the 
location of cell in the epithelium, stage of development of 
the epithelium and the relative stage of keratinocyte dif-
ferentiation and tissue development (23-28). Biochemical 
studies and studies with monoclonal antibodies demon-
strated 21 soft and 8 hard cytokeratins (20,21,29). Soft 
cytokeratins are divided into two main groups; group 1) 
relatively bigger and basic polypeptides, numbered from 
1 to 8, group 2) relatively smaller and acidic polypep-
tides numbered from 9 to 21. Epithelium is defined as its 
cytokeratin pattern. Differences of acidic and basic cy-
tokeratins are correlated with the diversity of epithelium. 
Studies have revealed that some of the general rules:
− filament formation needs polymerization of one acidic 
and one basic cytokeratin,
− cytokeratin 7,8,18 and 19 are located usually in simple 
epithelium,
− cytokeratin 5 and 14 are located in basal layers of stra-
tified and complex epithelium,
− cytokeratin 1,2,10 and 11 are located in suprabasal la-
yers of cornified epithelium,
− cytokeratin 4 and 13 are located in non-cornified 
epithelium,
− cytokeratin 6 and 16 are located in hyperproliferated 
epithelium,
− cytokeratin pattern of stratified epithelium may vary 
locally, for example differentiated cells of epidermis 
have cytokeratin 1 and 10,
− whereas non-keratinized oral mucosa has cytokeratin 
4 and 13.
The pattern may change in malign transformation, in the 
cell cultures, in the wound healing and in the case of in-
flammation. In the pathogenesis of inflammatory diseas-
es, cytokeratins express their role and act as messengers 
between cells. Cytokeratins are released by macrophages, 
lymphocytes and other cells at the site of infection and 
inflammation. Cytokeratin polypeptides can be demon-
strated by immunohistochemical methods using with 
monoclonal antibodies.
The mechanism of region-specific occurrence of cy-
tokeratins is not fully understood. During development, 
epithelial – mesenchymal relationships due to regional 
differences may be responsible for this.
In order to elucidate the pathogenesis of cholesteatoma, 
so many studies have been performed related to distri-
bution pattern of cytokeratins (28,30-42). Cytokeratins 
can be used as proliferation, migration and differentia-
tion markers. Studies on the appearance of cytokeratins 
in cholesteatoma revealed that cytokeratin pattern of 
cholesteatoma looks like external canal skin and points 
the hyperproliferative stage (31,35,36). Lee et al (43) used 
monoclonal antibodies for revealing and comparing the 
cytokeratin structure of normal canal skin and cholestea-
toma. He determined that there was not any difference 
in staining patterns. Kakoi et al (20) examined cytokerat-
ins of cholesteatoma and epithelial differentiations. They 
used cytokeratins of pharyngeal mucosa as control group 
and determined cytokeratin 1,5,10 and 14 in cholestea-
toma. Cytokeratin 5 and 14 were synthesized in basal 
lamina cells and are used as squamous epithelial marker. 
Otherwise cytokeratin 1-10 synthesized in suprabasal 
layer cells and they were the markers for keratinization 
in squamous epithelium or differentiation (44). Sasaki et 
al (45) studied cytokeratin 6 which was observed in epi-
dermal hyperproliferative stage in epidermis of choleste-
atoma and cytokeratin 13 which was observed in active 
cell proliferation in epidermal cells. In this immunohisto-
chemical study, cytokeratin 16 was showed in suprabasal 
layers of cholesteatoma, canal skin and tympanic mem-
brane. These results are similar to the results in active 
psoriatic lesions (46). According to Sasaki et al (45), these 
results suggest that cholesteatoma, canal skin and tym-
panic membrane are all in hyperproliferative stage. Ergun 
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et al (47) also observed the hyperproliferative nature of 
cholesteatoma. This study indicated the expression pat-
tern of epithelial markers in cholesteatoma corresponds 
to that in normal epidermis. Some think that cytokeratin 
distribution of cholesteatoma changes in different stages 
of the disease (17,40), as well as others who claim the op-
posite (42).
It is thought that epidermal cytokeratin pattern of cho-
lesteatoma points the epithelial migration, in addition 
non-epidermal cytokeratin points the hyperprolifera-
tive or ectopic metaplasia (35). There are various ultras-
tructural (28,36,39), immunhistochemical (23,31,33,35-
38,40,42,48,49) and clinic studies support that epidermal 
migration is the most common cause of cholesteatoma. 
When st. corneum layer of cholesteatoma is examined 
with electron microscopy, the findings are similar to the 
findings of deep part of external ear canal and pars flac-
cida part of tympanic membrane. This finding supports 
the hypothesis that cholesteatoma is formed from epi-
thelial migration of tympanic membrane and external ear 
canal (28). Immunohistochemical studies of cytokeratins 
indicate that cholesteatoma arises from keratinized epi-
thelium of tympanic membrane and canal (32,33,35,42). 
In some studies, it was shown that, in the region where 
normal epithelium meets cholesteatoma, there were ac-
tive keratinocytes indicating proliferation and migration 
(40,41). Nevertheless, normal squamous epithelium has 
not any migration capability to middle ear (30). For the 
migration of squamous epithelium, a formation like in-
flammation, granulation tissue or organized effusion is 
required acting as a bridge (41). Olszewska et al (50) stud-
ied with Ck 10-14-18-19-34 in congenital cholesteatoma 
epithelium, pediatric acquired cholesteatoma epithelium, 
middle ear mucosa, glandular epithelium and external 
ear canal (skin) epithelium. Olszewska et al demonstrated 
an identical expression pattern of Ck 10-14-18-19 and 34 
antigens in the matrix of congenital and acquired pedi-
atric cholesteatoma. According to Olszewska et al, this 
finding supports the hypothesis that both types of cho-
lesteatoma have an epidermal origin. In addition to this, 
in this study, the matrix of acquired cholesteatoma shows 
the same characteristics as the external matrix suggest-
ing the theory that cholesteatoma has an epidermal ori-
gin. Lepercque et al (48) observed a similar cytokeratin 
pattern in middle ear cholesteatoma, annular region of 
the external meatus and the lateral side of eardrum. With 
these findings Lepercque et al stated that cholesteatoma 
originates from external ear canal or the lateral side of the 
tympanic membrane.
Epithelial cell proliferation is another mechanism pro-
posed in the pathogenesis of cholesteatoma. Some 
studies have defined the hyperproliferated behavior of 
cholesteatoma epithelium according to the expression 
of Ck 4,10,13,14,16 and 19 (37,51-53). This theory was 
supported by experimental animal (23,36) and human 
(35,38,49) studies. In their experimental study which was 
conducted with cytokeratins, Vennix et al (40) argued that 
cholesteatoma has an epidermal origin. They advocated 
that non-epidermal cytokeratins like Ck 4, Ck 13 and Ck 
16 indicate hyperproliferation rather than metaplasia. 
They also added that infection cause proliferation of ca-
nal epidermis which transplanted in middle ear, and this 
finding supported the progression of cholesteatoma was 
connected to inflammatory process (23). Increased ap-
pearance of Ck 13 and 16 which are the markers of hy-
perproliferative keratinocytes has been shown in chole-
steatoma (38,46,49,54). In immunohistochemical studies, 
there are remarkable differences between the intensity 
and localization of certain cytokeratins. These changes 
may be related to an altered process of differentiation. 
Olszewska et al observed Ck 10 in all suprabasal cell lay-
ers of the meatal skin and congenital cholesteatoma. Ck 
10 is known as a keratinization marker and corresponds 
the extent of differentiation within keratinocytes. While 
Olszewska et al (50) considered that Ck 10 expression 
was affected by the extent of cholesteatoma like Kim et 
al (53), others demonstrated a decrease of Ck 10 expres-
sion in cholesteatoma (37,55,59). Liang et al (52) observed 
the expression of Ck 10 in the granular and spinous layers 
of the external ear canal epidermis and superficial layer 
of epidermoid formation. While Liang et al didn’t observe 
positive immunohistochemical reaction with staining for 
Ck 19 within basal and suprabasal keratinocytes in the 
epidermis or in the cholesteatoma epithelium, Olszewska 
et al observed definitely positive reactions with Ck 19 an-
tibodies within the middle ear mucosa around the glands. 
Results of immunohistochemical staining reactions for cy-
tokeratins at various epithelial cites and cholesteatoma in 
different studies were summarized in Table 1. Stainig epi-
thelial sites are meatal skin, cartilage and bone of external 
ear canal, medial and lateral sides of tympanic membrane, 
middle ear mucosa and glandular epithelium. Cytokeratin 
4,5,7,8,10,13,14,16,18,19 and 34bE12 were studied. In 
cholesteatoma, all of these were observed in almost all 
studies. In epithelial sites, a dispersion was observed. 
Studies suggest that increasing number of researches 
about cytokeratins will also increase our understanding of 
pathogenesis of cholesteatoma. Progress about this sub-
ject will support surgical and medical treatments.  
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Table 1. Results of immunohistochemical staining reactions for cytokeratins at various epithelial cites and cholesteatoma in different studies.
Ck 4 Ck 5 Ck 7 Ck 8 Ck 10 Ck 13 Ck 14 Ck 16 Ck 18 Ck 19 Ck34bE12
Meatal skin +
(53,58)
-(35,59)
+
(35,59)
-
(35,59)
-
(35,59)
+
(35,47,50,53,58,59)
+
(53)
-(35,59)
+
(35,47,59)
-(50,58)
±
(35,59)
-
(35,50,58,59)
-
(35,50,58,59)
+
(50,58)
External ear canal
(cartilage)
-(48) +(48) -(48) - (48) +(48) -(48) +(48) -(48) -(48) -(48)
External ear canal
(bone)
-(48) +(48) -(48) -(48) +(48) -(48) +(48) +(48) -(48) +(48)
Tympanic membrane +(53) +(53) +(47,53) +(53) +(47)
Tympanic membrane
(lateral side)
-(48) +(48) -(48) -(48) +(48) -(48) +(48) +(48) -(48) +(48)
Tympanic membrane
(medial side)
+(48) -(48) +(48) +(48) -(48) +(48) +(48) -(48) +(48) +(48)
Middle ear 
mucosa
+
(58)
-
(35,53,59)
+
(35,59)
-
(53)
-
(35,59)
-
(35,59)
+
(47,53,58)
-
(35,50,59)
-
(35,53,59)
+(35,47,59)
-(50)
±(58)
+
(35,59)
-
(35,50,58,59)
+
(50,58)
-
(35,59)
-
(50,58)
Cholesteatoma +
(58)
±
(35,59)
+
(35,59)
±
(35,59)
±
(35,59)
+
(35,47,50,58,59)
±
(35,59)
+
(35,47,50,59)
±
(58)
+
(35,59)
±
(35,59)
-
(50,58)
±
(35,59)
-
(50,58)
+
(50,58)
Middle ear glandular 
epithelium
-(58) -(50,58) -(50,58) -(50,58) +(50,58) -(50,58)
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